(Q54705428)

3 June 2018

title

Trastuzumab-related cardiac events in the treatment of early breast cancer. (English)

1 reference

3 June 2018

author name string

Georgeta Fried

series ordinal

1

1 reference

3 June 2018

Tslil Regev

series ordinal

2

1 reference

3 June 2018

Mor Moskovitz

series ordinal

3

1 reference

3 June 2018

language of work or name

English

0 references

publication date

24 October 2013

1 reference

3 June 2018

Breast Cancer Research and Treatment

published in

1 reference

3 June 2018

volume

142

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

1-7

1 reference

3 June 2018

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Adjuvant trastuzumab in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2732-6

10.1007/S10549-013-2732-6

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018